20111 results for «»
20111 results
TRISCEND II Pivotal Trial : How will TTVR impact the treatment of tricuspid regurgitation?
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Marianna Adamo, Philipp Lurz, and Sam Dawkins explore the one-year outcomes of the TRISCEND II Pivotal Trial, highlighting its potential to redefine the management of severe tricuspid regurgitation. They delve into the trial’s impact on patients’ quality of life, examine its limitations,...
Impact of late-breaking clinical evidence on your daily mitral TEER practice
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Tobias Geisler, Maurizio Taramasso, and Robert Smith delve into the late-breaking trials presented at PCR London Valves 2024. They examine the CLASP IID study, which compares TEER devices for severe mitral regurgitation, and the MiCLASP study, evaluating edge-to-edge therapy approaches. Together, they...
A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system
25 Nov 2024 – From PCR London Valves 2024
Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...
Bicaval TricValve in severe tricuspid regurgitation: one-year outcomes from the Tricbicaval Registry
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion between Angel Sanchez Recalde and Fernando Sarnago, discover the latest updates from the Tricbicaval Registry, as experts discuss the TricValve system for managing severe tricuspid regurgitation. Learn about the patient profiles included in the registry, its promising initial results, and how it...
Empire one: first-in-human study of a new transcatheter aortic valve system
25 Nov 2024 – From PCR London Valves 2024
Join this roundtable discussion with Nicola Ryan and José Antonio Baz Alonso as they delve into the Empire One trial outcomes. Learn about the IMPERIA™ delivery system for the ALLEGRA™ heart valve, its unique features, and trial results, including detailed hemodynamic findings. Hear insights on its...
Contemporary treatment for Small Aortic Annuli in 2024
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Gunasekaran Sengottuvelu, Viveka Kumar, and Haresh Mehta explore optimal treatment strategies and the selection of valve types for challenging anatomies such as small annuli—a condition prevalent in a significant portion of the Indian population.
This interview was filmed at PCR London Valves 2024:...
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
Mitral valvuloplasty - A new look at an old procedure
24 Nov 2024 – From PCR London Valves 2024
Want to sharpen your expertise in mitral valvuloplasty? This video gets straight to the point: learn the best technical approaches, tackle tough clinical decisions with confidence and discover how to manage mitral stenosis during pregnancy!
Through the lens of a compelling real-world case—a 32-year-old pregnant patient with...
The many faces of complex TAVI
25 Nov 2024 – From PCR London Valves 2024
Learn how to navigate challenging cases illustrating the complexities of TAVI procedures and the importance of device selection and implantation technique. Discover strategies for tackling issues like bicuspid aortic stenosis, difficult access, and complex anatomies.
Tricuspid valve intervention - Current indications and timing
24 Nov 2024 – From PCR London Valves 2024
Curious about the latest breakthroughs in tricuspid valve interventions? This video dives right in, showing you how to assess patients with severe tricuspid regurgitation, interpret imaging and biomarkers and apply cutting-edge evidence from randomized trials to real-world cases.
Through 3 compelling clinical cases—each highlighting different stages and...
TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
Featured research - Aortic valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Dive into the latest research on aortic valve interventions in this two-part featured research session. Explore a wide range of topics, including the safety and efficacy of novel transcatheter aortic valve systems, hemodynamic outcomes, risk scoring, and peri-procedural considerations.
Featured cases - Mitral valve-in-valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a collection of captivating clinical cases focused on mitral valve-in-valve procedures. Learn from experienced practitioners as they share their approaches to addressing complex challenges, such as paravalvular leaks, difficult anatomies, and innovative techniques.
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
Featured cases - TAVI nightmares (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Featured research - Mitral valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Dive deeper into the latest mitral valve research in this second part of the featured research session. Uncover insights from cutting-edge studies on the TEND-RING Tendyne mitral valve-in-ring registry, the feasibility and results of mitral valve clipping after failed surgical repair, outcomes of TEER for primary...
Featured cases - Challenging tricuspid interventions (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Dive into this session showcasing a diverse array of challenging tricuspid interventions from the PCR London Valves 2024 Clinical Cases submissions. Discover complex cases involving TTVR in a transplanted heart, recurrent tricuspid regurgitation after T-TEER, and an extremely difficult tricuspid valve-in-valve implantation. Gain insights on navigating...
Featured cases - TAVI embolisation (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a captivating collection of featured TAVI cases from PCR London Valves 2024. Witness the management of complex complications such as valve embolization, retrograde migration, and coronary sequestration. Discover innovative percutaneous retrieval techniques, cases of multiple valves in TAVI, and strategies for handling acute valve migration...
Featured cases - TAVI coronary complications
24 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected PCR London Valves 2024 Clinical Cases submissions on TAVI coronary complications. Explore a case of post-TAVR acute pulmonary edema, an unusual inter-TAVI diastolic gradient, late coronary artery occlusion after TAVR-in-SAVR, acute coronary syndrome after TAVI due to subacute left main...
